Carbamazepine-induced systemic lupus erythematosus.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1393348.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 21-year-old woman suffering from bipolar affective disorder developed systemic lupus erythematosus (SLE) with characteristic laboratory findings, 18 months after starting carbamazepine maintenance treatment. SLE receded after withdrawal of carbamazepine and treatment with anti-inflammatory drugs. Although both the spontaneous occurrence of SLE and the psychosis as a sign of CNS involvement of SLE cannot be excluded, SLE could be considered as an adverse effect of carbamazepine.
Medical subject headings
- Bipolar Disorder
- Carbamazepine
- Lupus Erythematosus, Systemic